Last Updated: September 28, 2026

Sagent Pharms Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SAGENT PHARMS INC

SAGENT PHARMS INC has fifty-five approved drugs.

Summary for Sagent Pharms Inc

US Patents:	0
Tradenames:	47
Ingredients:	46
NDAs:	55

Drugs and US Patents for Sagent Pharms Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sagent Pharms Inc	PHENYLEPHRINE HYDROCHLORIDE	phenylephrine hydrochloride	SOLUTION;INTRAVENOUS	209967-003	Jan 16, 2020	AP1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	FLUDARABINE PHOSPHATE	fludarabine phosphate	INJECTABLE;INJECTION	076661-001	Apr 28, 2004	AP1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	GEMCITABINE HYDROCHLORIDE	gemcitabine hydrochloride	INJECTABLE;INJECTION	209077-002	Jul 20, 2018	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	VECURONIUM BROMIDE	vecuronium bromide	INJECTABLE;INJECTION	078274-002	Dec 29, 2008	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	METHYLPREDNISOLONE SODIUM SUCCINATE	methylprednisolone sodium succinate	INJECTABLE;INJECTION	040888-002	Jul 18, 2011	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.